Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival. [electronic resource]
- Cancer Jun 2014
- 1677-85 p. digital
Publication Type: Journal Article
1097-0142
10.1002/cncr.28642 doi
Adult Aged Aged, 80 and over Antibodies, Monoclonal, Murine-Derived--therapeutic use Antineoplastic Combined Chemotherapy Protocols--therapeutic use Cyclophosphamide--therapeutic use Disease-Free Survival Doxorubicin--therapeutic use Female Genes, bcl-2 Humans Induction Chemotherapy Lymphoma, Non-Hodgkin--chemistry Male Middle Aged Positron-Emission Tomography Prednisone--therapeutic use Proto-Oncogene Proteins c-myc--analysis Rituximab Tomography, X-Ray Computed Vincristine--therapeutic use